Loading...
Loading...
India's telmisartan imports from UNITED STATES total $216.4K across 157 shipments from 15 foreign suppliers. NEWLIFE MEDICALS (USA). INC leads with $159.1K in import value; the top 5 suppliers together control 93.8% of this origin. Leading Indian buyers include IPCA LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for telmisartan — a diversified sourcing base with multiple active suppliers from UNITED STATES.

NEWLIFE MEDICALS (USA). INC is the leading Telmisartan supplier from UNITED STATES to India, with import value of $159.1K across 3 shipments. The top 5 suppliers — NEWLIFE MEDICALS (USA). INC, AMNEAL PHARMACEUTICALS OF LLC, AGRACE PHARMA, AMSTERDAM PHARMA (APTEKA RX INC), ESPEE BIOPHARMA & FINECHEM LLC — collectively account for 93.8% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NEWLIFE MEDICALS (USA). INC | $159.1K | 3 | 73.5% |
| 2 | AMNEAL PHARMACEUTICALS OF LLC | $15.8K | 122 | 7.3% |
| 3 | AGRACE PHARMA | $12.3K | 8 | 5.7% |
| 4 | AMSTERDAM PHARMA (APTEKA RX INC) | $8.9K | 2 | 4.1% |
| 5 | ESPEE BIOPHARMA & FINECHEM LLC | $6.8K | 2 | 3.2% |
| 6 | AMSTERDAM PHARMA (APTEKA RX. INC) | $2.8K | 1 | 1.3% |
| 7 | Espee Biopharma & Finechem LLC | $2.6K | 1 | 1.2% |
| 8 | SPRING BIO SOLUTION | $2.3K | 3 | 1.1% |
| 9 | NEW LIFE MEDICALS (USA),INC. | $1.8K | 4 | 0.8% |
| 10 | AMSTERDAM PHARMA (APTEKA RX INC.) | $1.3K | 1 | 0.6% |
| 11 | ESPEE BIOPHARMA & FINECHEM LLC. | $1.2K | 1 | 0.6% |
| 12 | ESPEE BIOPHARMA & FINECHEM LLC.. | $1.1K | 1 | 0.5% |
| 13 | AJANTA PHARMA PHILIPPINES INC | $179 | 1 | 0.1% |
| 14 | AMNEALPHARMACEUTICALS OF LLC | $138 | 3 | 0.1% |
| 15 | AMSTERDAM PHARMA APTEKA RX INC | $10 | 4 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED | $173.3K | 6 | 80.1% |
| 2 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $16.0K | 125 | 7.4% |
| 3 | AJANTA PHARMA LIMITED | $12.1K | 12 | 5.6% |
| 4 | MSN LABORATORIES PRIVATE LIMITED | $6.1K | 4 | 2.8% |
| 5 | ZENRISE CLINICAL RESEARCH PRIVATE LIMITED | $2.6K | 1 | 1.2% |
| 6 | MICRO LABS LIMITED | $1.9K | 2 | 0.9% |
| 7 | ALEMBIC PHARMACEUTICALS LIMITED | $1.8K | 4 | 0.8% |
| 8 | MICRO LABS LTD | $1.5K | 2 | 0.7% |
| 9 | EXEMED PHARMACEUTICALS | $1.2K | 1 | 0.6% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Telmisartan suppliers from UNITED STATES to India include NEWLIFE MEDICALS (USA). INC, AMNEAL PHARMACEUTICALS OF LLC, AGRACE PHARMA. The leading supplier is NEWLIFE MEDICALS (USA). INC with import value of $159.1K USD across 3 shipments. India imported Telmisartan worth $216.4K USD from UNITED STATES in total across 157 shipments.
India imported Telmisartan worth $216.4K USD from UNITED STATES across 157 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Telmisartan sourced from UNITED STATES include IPCA LABORATORIES LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, AJANTA PHARMA LIMITED. The largest buyer is IPCA LABORATORIES LIMITED with $173.3K in imports across 6 shipments.
The total value of Telmisartan imports from UNITED STATES to India is $216.4K USD, across 157 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
157 Verified Shipments
15 suppliers, 9 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists